Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
Die Kommerzialisierung der räumlichen Intelligenz in Billionen-Märkten beginnt jetzt
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3E2E9 | ISIN: US09060C5076 | Ticker-Symbol:
NASDAQ
13.02.26 | 21:59
0,600 US-Dollar
-3,27 % -0,020
Branche
Software
Aktienmarkt
Sonstige
1-Jahres-Chart
BIO-KEY INTERNATIONAL INC Chart 1 Jahr
5-Tage-Chart
BIO-KEY INTERNATIONAL INC 5-Tage-Chart
GlobeNewswire (Europe)
332 Leser
Artikel bewerten:
(2)

BIO-key International, Inc.: BIO-key Secures Significant Identity and Biometric Security Deployment with a Major Middle East Defense Sector Organisation

HOLMDEL, N.J. and RIYADH, Saudi Arabia, Nov. 07, 2025 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (NASDAQ: BKYI), a global leader in Identity and Access Management (IAM) and biometric authentication technologies, has secured a significant new deployment with a major defense-sector security organisation in the Middle East. The solution will support critical infrastructure and sensitive access environments using BIO-key's advanced biometric and multi-factor authentication technologies. The customer requested that their identity not be disclosed for security reasons.

The contract represents one of BIO-key's largest security-sector deployments in the region to date and extends its growing footprint in high-assurance government and defense environments. The customer selected BIO-key to strengthen access security, streamline credential management, and deliver biometric-based authentication-without reliance on mobile devices or hardware tokens.

The deployment is the result of BIO-key's new strategic partnership with Cloud Distribution, a leading Saudi-based Value-Added Distributor. BIO-key's collaboration with Cloud Distribution has accelerated opportunities across the region by combining world-class IAM solutions with seasoned, local cybersecurity expertise and strong in-country delivery capabilities.

"This deployment reinforces BIO-key's strategic commitment to supporting national security and critical infrastructure protection in the Middle East," said Alex Rocha, Managing Director International, BIO-key International. "Our Identity-Bound Biometric solutions are designed to deliver the highest levels of assurance without adding operational complexity. This project reflects the trust placed in BIO-key's technology to secure the most sensitive environments, and we are honoured to collaborate with Cloud Distribution to make it a reality."

About BIO-key International, Inc. (www.BIO-key.com)
BIO-key is revolutionizing authentication and cybersecurity with biometric-centric, multi-factor identity and access management (IAM) software securing access for over forty million users. BIO-key allows customers to choose the right authentication factors for diverse use cases, including phoneless, tokenless, and passwordless biometric options. Its cloud-hosted or on-premise PortalGuard IAM solution provides cost-effective, easy-to-deploy, convenient, and secure access to computers, information, applications, and high-value transactions.

BIO-key Safe Harbor Statement
All statements contained in this press release other than statements of historical facts are "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Act"). The words "estimate," "project," "intends," "expects," "anticipates," "believes" and similar expressions are intended to identify forward-looking statements. Such forward-looking statements are made based on management's beliefs, as well as assumptions made by, and information currently available to, management pursuant to the "safe-harbor" provisions of the Act. These statements are not guarantees of future performance or events and are subject to risks and uncertainties that may cause actual results to differ materially from those included within or implied by such forward-looking statements. These risks and uncertainties include factors set forth under the caption "Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2024 and other filings with the SEC. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date made. Except as required by law, we undertake no obligation to disclose any revision to these forward-looking statements, whether as a result of new information, future events, or otherwise.

Engage with BIO-key Corporate

Facebook:https://www.facebook.com/BIOkeyInternational/
LinkedIn:https://www.linkedin.com/company/bio-key-international
X:
@BIOkeyIntl
Investors
X:@BIO_keyIR
StockTwits:@BIO_keyIR

Investor Contacts
William Jones, David Collins
Catalyst IR
BKYI@catalyst-ir.com or 212-924-9800


© 2025 GlobeNewswire (Europe)
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.